Pro-inflammatory mechanisms in sepsis

Contributions to Microbiology

Volumn 17, Issue , 2011, Pages 86-107

  Chong, Deborah L W ^a   Sriskandan, Shiranee ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN RECEPTOR;

ARTICLE; BACTERIAL INFECTION; HUMAN; MYCOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIAL INFECTIONS; HUMANS; MYCOSES; RECEPTORS, IMMUNOLOGIC; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BACTERIA (MICROORGANISMS);

EID: 84926098364     PISSN: 14209519     EISSN: 1662291X     Source Type: Book Series    
DOI: 10.1159/000324022     Document Type: Article

References (40)

1. de Jong HK, van der Poll T, Wiersinga WJ: The systemic pro-inflammatory response in sepsis. J Innate Immun. 2010;2:422-430.
2. Barton GM, Kagan JC: A cell biological view of Tolllike receptor function: Regulation through compartmentalization. Nat Rev Immunol 2009;9:535-542.
3. Chang ZL: Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res 2010;59:791-808.
4. Akira S: Toll-like receptor signaling. J Biol Chem 2003;278:38105-38108.
5. Pene F, Courtine E, Ouaaz F, Zuber B, Sauneuf B, Sirgo G, Rousseau C, Toubiana J, Balloy V, Chignard M, Mira J, Chiche J: Toll-like receptors 2 and 4 contribute to sepsis-induced depletion of spleen dendritic cells. Infect Immun 2009;77:5651-5658.
6. Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson A, Mauri D, Burns K, Riederer BM, Akira S, Calandra T: Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA 2009;106:2348-2352.
7. Plitas G, Burt BM, Nguyen HM, Bamboat ZM, DeMatteo RP: Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J Exp Med 2008; 205:1277-1283.
8. Brodsky IE, Monack D: NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin Immunol 2009;1: 199-207.
9. Franchi L, Munoz-Planillo R, Reimer T, Eigenbrod T, Nunez G: Inflammasomes as microbial sensors. Eur J Immunol 2010;40:611-615
10. Takeuchi O, Akira S: Pattern recognition receptors and inflammation. Cell 2010;140:805-820.
11. Sriskandan S, Unnikrishnan M, Krausz T, Cohen J: Molecular analysis of the role of streptococcal pyogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Mol Micro 1999;33:778-790.
12. Sriskandan S, Altmann DM: The immunology of sepsis. J Pathol 2008;214:211-223.
13. Llewelyn M: Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock. Clin Infect Dis 2005; 41(suppl 7): S445-S448.
14. Unnikrishnan M, Altmann DM, Proft T, Wahid F, Cohen J, Fraser JD, Sriskandan S: The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol 2002;169:2561-2569.
15. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, Valentine C, Hellamn J: MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007;178:1164-1171.
16. Paul-Clark MJ, Sorrention R, Bailey LK, Sriskandan S, Mitchell JA: Gram-positive and Gram-negative bacteria synergize with oxidants to release CXCL8 from innate immune cells. Mol Med 2008;14: 238-246.
17. Lin T, Kwak YH, Sammy F, He P, Thundivalappil S, Sun G, Chao W, Warren HS: Synergistic inflammation is induced by blood degradation products with microbial toll-like receptor agonists and is blocked by hemopexin. J Infect Dis 2010;202:624-632.
18. Huby RD, Dearman RJ, Kimber I: Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J Biol Chem 1999;274:22591-22596.
19. Zilber MT, Gregory SH, Mallone R, Deaglio S, Malavasi F, Charron D, Gelin C: CD38 expressed on human monocytes: A coaccessory molecule in the superantigen-induced proliferation. Proc Natl Acad Sci USA 2000;97:2840-2845.
20. Zilber MT, Setterblad N, Vasseoln T, Doliger C, Charron D, Monney N, Gelin C: MHC class II/CD38/ CD9: A lipid-raft-dependent signaling complex in human monocytes. Blood 2005;106:3074-3081.
21. Dinarello CA: Proinflammatory cytokines. Chest 2000;111:503-508.
22. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194:519-527.
23. Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ferrara JL, Ward PA: Adverse functions of IL-17A in experimental sepsis. FASEB J 2008;22: 2198-2205.
24. Flammer AJ, Luscher TF: Human endothelial dysfunction: EDRFs. Pflugers Arch 2010;459: 1005-1013.
25. Dauphinee SM, Karsan A: Http://www.nature.com/ labinvest/journal/v86/n1/ full/3700366a.html -aff1 Lipopolysaccharide signaling in endothelial cells. Lab Invest 2006;86:9-22.
26. Jimenez R, Belcher E, Sriskandan S, Lucas R, McMaster S, Vojnovic I, Warner TD, Mitchell JA: Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle. Proc Natl Acad Sci USA 2005;102:4637-4642.
27. Cartwright N, McMaster SK, Sorrentino R, Paul-Clark M, Sriskandan S, Ryffel B, Quesniaux VF, Evans TW, Mitchell JA: Elucidation of toll-like receptor and adapter protein signaling in vascular dysfunction induced by gram-positive Staphylococcus aureus or gram-negative Escherichia coli. Shock 2007;27:40-47.
28. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY: Molecular mechanisms of endothelial hyperpermeability: Implications in inflammation. Expert Rev Mol Med 2010;11:e19.
29. Yano K, Liaw PC, Mullington JM, Shih SC, Okada H, Bodyak N, Kang PM, Toltl L, Belikoff B, Buras J, Simms BT, Mizgerd JP, Carmeliet P, Karumanchi SA, Aird WC: Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med 2006;203:1447-1458.
30. Guo R-F, Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol 2005;23:821-852.
31. Schraufstatter IU, Trieu K, Sikora L, Sriramarao P, DiScipio R: Complement C3a and C5a induce different signal transduction cascades in endothelial cells. J Immunol, 2002;169:2102-2110.
32. Riewald M, Ruf W: Role of coagulation protease cascades in sepsis. Critical Care 2003;7:123-129.
33. Levi M, van der Poll T: Inflammation and coagulation. Crit Care Med 2010;38(suppl):S26-S34.
34. Sriskandan S, Cohen J: Kallikrein-kinin system activation in streptococcal toxic shock syndrome. Clin Infect Dis 2000;30:961-962.
35. Frick I-M, Bjorck L, Herwald H: The dual role of the contact system in bacterial infectious disease. Thromb Haemost 2007;98:497-502.
36. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER: Neutrophil kinetics in health and disease. Trends Immunol 2010;31:318-324.
37. Linder A, Soehnlein O, Akesson P: Roles of heparin-binding protein in bacterial infection. J Innate Immun 2010;2:431-438.
38. Gautam N, Olofsson AM, Herwald H, Iversen LF, Lundgren-Akerlund E, Hedqvist P, Arfors KE, Flodgaard H, Lindbom L: Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability. Nature Med 2001;7:1123-1127.
39. Vanlaere I, Libert C: Matrix Metalloproteinases as drug targets in infections caused by Gram-negative bacteria and in septic shock. Clin Microbiol Rev 2009;22:224-239.
40. Stables MJ, Gilroy DW: Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res 2011;50:35-51.